WebDetected Diabetes in Primary Care(ADDITION) trial was set up in three countries: England (Cambridge and Leices-ter), Denmark and The Netherlands to provide evidence on screening for type 2 diabetes and the effects of early intensive multifactorial treatment [20]. We present the protocol of the Cambridge component of this trial. Target population WebADDITION-Cambridge is a cluster randomised controlled trial of a population-based screening for type 2 diabetes followed by intensive multifactorial treatment compared with routine care. 12 The trial was conducted in the East of England and recruited 867 people with type 2 diabetes in 49 general practices across urban, suburban, and rural areas.
BMJ Open
WebThe ADDITION trial was the first RCT of screening and intensive intervention to reduce cardiovascular risk. The main findings were that screening and intervention are feasible, but that intervention did not … WebMay 12, 2009 · The ADDITION-Cambridge study aims to evaluate the effectiveness and cost-effectiveness of a stepwise screening strategy for type 2 diabetes; and intensive multifactorial treatment for people with screen-detected diabetes in primary care. BackgroundThe increasing prevalence of type 2 diabetes poses a major public health … cider no you ni kotoba ga wakiagaru ver online
Screening for type 2 diabetes and population mortality …
WebNov 17, 2012 · Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial Wellcome Trust; UK … WebDec 1, 2024 · We analyzed the electronic primary care records of a subsample of the ADDITION-Cambridge trial cohort (n = 173). Unit costs of used primary care services were taken from the published literature. Incremental annual costs of intensive treatment versus routine care in years 1 to 5 after diagnosis were calculated using multilevel generalized ... WebMethods. Eight hundred and sixty-seven individuals with screen-detected diabetes underwent measurement of self-reported physical activity, cardiovascular disease risk factors and modelled cardiovascular disease risk at baseline and 1 year (n = 736) in the ADDITION-Cambridge trial.Multiple linear regression was used to quantify the … cidi j03